BACKGROUND Cancer and cisplatin‐based chemotherapy both are well recognized risk
factors for coagulation disorders and thrombosis. However, vascular events (VEs) seldom …

INTRODUCTION: The purpose of this study is to retrospectively analyze acute toxicity
encountered in young and old patients treated with chemo-radiation or bio-radiation at the S …

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced
Non–Small-Cell Lung Cancer: Results of th Page 1 Pemetrexed Versus Pemetrexed and …

Background Despite sensitivity to first-line chemotherapy, most small-cell lung cancer
(SCLC) patients relapse. In this setting, topotecan demonstrated modest activity with …

Based on improved survival from the addition of PD-L1 inhibitors in phase III trials, the
combination of immunotherapy and platinum-doublet chemotherapy has become the new …

Head and neck cancer may be easily controlled at early stages, but resectable locally
advanced disease often relapses at T and N sites. Therefore, adequate adjuvant treatment is …

Background Several strategies have been investigated to improve the 4% survival
advantage of adjuvant chemotherapy in early-stage non-small-cell lung cancer (NSCLC). In …

Malignant pericardial effusion (MPE) is a serious complication of several cancers. The most
commonly involved solid tumors are lung and breast cancer. MPE can give rise to the …

Objectives Despite the scant docetaxel's tolerability, second-line association with nintedanib
still represents a standard-of-care for non-squamous non-small cell lung cancer (nsNSCLC) …

Purpose Survival prediction is useful in selecting patients for palliative care or active
anticancer therapy. The palliative and prognostic (PaP) score was shown to predict 1-month …